Bulletin Board
Bulletin Board
Senate Committee Looks at 340B
Last week the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the 340B Drug Pricing Program, which provides discounted prescription drugs to eligible health care providers, known as "covered entities," to help them serve low-income and uninsured patients. In recent years the 340B program has become more controversial as it has grown and as pharmaceutical companies object more strenuously to the discounts they are required to provide to participating providers. In addition, some critics charge that the savings providers gain from 340B discounts are not consistently [...]
Impact of H-1B Visa Fee on Hospitals in Underserved and Rural Areas
The new $100,000 fee for H-1B visas is expected to detract from the ability of providers in low-income and rural areas to serve their communities. Providers – especially hospitals – in such areas typically operate on very low margins and always have trouble recruiting physicians and other highly skilled providers and often turn to international medical graduates in search of help. In fact, a 2021 study published by the National Institutes of Health reported that nearly two-thirds of international medical graduates practiced in areas designated as health professional shortage areas [...]
The Struggle to Help Prove Medicaid Eligibility
With new Medicaid work rules scheduled to take effect in 42 states by the end of 2026, policymakers are working to find new, better ways to enable Medicaid applicants to demonstrate that they are meeting Medicaid work and community engagement requirements. While the Centers for Medicare & Medicaid Services has set aside $200 million to pursue technology solutions for this problem, such efforts, at least so far, have not proven successful. In a test in Louisiana, for example, state officials sent text messages to 13,000 Medicaid enrollees, asking them to [...]
Lack of Confidence Spawns MMWR Alternative
Citing a growing lack of confidence in federal public health reporting, the New England Journal of Medicine and the Center for Infectious Disease Research and Policy are creating a private sector alternative to the Centers for Disease Control and Prevention’s long-running Morbidity and Mortality Weekly Report (MMWR). To be launched in the next month or so, the two organizations will begin publishing what they call “public health alerts” that will be available for free, and published as needed, in a new section of the NEJM Evidence. In creating the new [...]
Senate Committee Looks at 340B
Last week the Senate Committee on Health, Education, Labor and Pensions held a hearing on the 340B Drug Pricing Program to discuss its growth and impact on patients. Among other subjects, the committee reviewed the importance of the 340B program; the pharmaceutical manufacturers’ rebate program that begins in January; potential transparency reforms; ensuring that 340B entities do not receive duplicate drug discounts; revising the definition of a patient for a covered entity; and reforms involving the use of contract pharmacies. Representatives from the Government Accountability Office, Congressional Budget Office (CBO), UCLA [...]